New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting
ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children
Zevalin Regimen Effective In Mantle Cell Lymphoma
Fondaparinux Prevents DVT In Acutely III Medical Patients
Clinical Trials Approved By NCI
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Galleri MCD vote: What FDA asked its advisors to ignore
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









